IOL Chemicals And PharmaceuticalsNSE:IOLCP +2.08%63 ROC (Joel Greenblatt) % is 17.18% as of Mar. 2026, which is 16% above its 10-year median of 14.83. GuruFocus rates NSE:IOLCP with a GF Score™ of 63/100 and a GF Value™ of ₹93.83 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 976 Drug Manufacturers companies, IOL Chemicals And Pharmaceuticals ranks better than 50.51% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. IOL Chemicals And Pharmaceuticals's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 17.18%.
The historical rank and industry rank for IOL Chemicals And Pharmaceuticals's ROC (Joel Greenblatt) % or its related term are showing as below:
NSE:IOLCP'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 9.66 Med: 14.83 Max: 71.39
Current: 11.65
During the past 13 years, IOL Chemicals And Pharmaceuticals's highest ROC (Joel Greenblatt) % was 71.39%. The lowest was 9.66%. And the median was 14.83%.
NSE:IOLCP's ROC (Joel Greenblatt) % is ranked better than 50.51% of 976
companies
in the Drug Manufacturers industry
Industry Median: 11.405
vs NSE:IOLCP: 11.65
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IOL Chemicals And Pharmaceuticals ROC (Joel Greenblatt) % Chart
NSE:IOLCP vs ZTS, UTHR: ROC (Joel Greenblatt) % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, IOL Chemicals And Pharmaceuticals's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IOL Chemicals And Pharmaceuticals ROC (Joel Greenblatt) % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, IOL Chemicals And Pharmaceuticals's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where IOL Chemicals And Pharmaceuticals's ROC (Joel Greenblatt) % falls into.
IOL Chemicals And Pharmaceuticals ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 17.18% mean?
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) has a ROC (Joel Greenblatt) % of 17.18% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. This is 16% above median its historical median of 14.83. Over the past decade, IOL Chemicals And Pharmaceuticals' ROC (Joel Greenblatt) % has ranged from 9.66 to 71.39. According to the industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #483 out of 976 companies in the Drug Manufacturers industry, placing it in the top 49.5%.
Is IOL Chemicals And Pharmaceuticals' ROC (Joel Greenblatt) % too high?
IOL Chemicals And Pharmaceuticals' current ROC (Joel Greenblatt) % of 17.18% is 16% above median its 10-year median of 14.83. Over the past 10 years, this metric has ranged from a low of 9.66 to a high of 71.39. The Drug Manufacturers industry median ROC (Joel Greenblatt) % is 11.41. IOL Chemicals And Pharmaceuticals' value of 17.18% is 50.6% above this industry median. Based on the distribution chart, IOL Chemicals And Pharmaceuticals ranks #483 out of 976 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, IOL Chemicals And Pharmaceuticals has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IOL Chemicals And Pharmaceuticals' ROC (Joel Greenblatt) % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #483 out of 976 companies for ROC (Joel Greenblatt) %. This puts IOL Chemicals And Pharmaceuticals in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 11.41. IOL Chemicals And Pharmaceuticals' value of 17.18% is 50.6% above this benchmark. Historically, IOL Chemicals And Pharmaceuticals' own ROC (Joel Greenblatt) % has ranged from 9.66 to 71.39 over the past decade. While the company's 10-year median is 14.83 vs. the industry median of 11.41, IOL Chemicals And Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Drug Manufacturers company?
The median ROC (Joel Greenblatt) % among Drug Manufacturers companies is 11.41, based on 976 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IOL Chemicals And Pharmaceuticals's current ROC (Joel Greenblatt) % of 17.18% is 50.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median ROC (Joel Greenblatt) % is 11.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IOL Chemicals And Pharmaceuticals's current ROC (Joel Greenblatt) % is 17.18%, which is 16% above median its own 10-year median of 14.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IOL Chemicals And Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals (NSE:IOLCP) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹93.83, compared to a current price of ₹145.29 — trading 54.8% above its estimated fair value. The current ROC (Joel Greenblatt) % is 17.18%, which is 16% above median its 10-year median of 14.83 and 50.6% above the Drug Manufacturers industry median of 11.41. IOL Chemicals And Pharmaceuticals' overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For IOL Chemicals And Pharmaceuticals (NSE:IOLCP), the current ROC (Joel Greenblatt) % is 17.18% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Overvalued in 2026?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals stock appears to be overvalued.
The current stock price of ₹145.29 is trading 54.8% above its estimated GF Value™ of ₹93.83.
GuruFocus considers IOL Chemicals And Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for NSE:IOLCP:
ROC (Joel Greenblatt) %: 17.18% (16% above median its 10-year median of 14.83)
GF Value™: ₹93.83 vs. price of ₹145.29 (54.8% above fair value)
Industry Position: 50.6% above the Drug Manufacturers median (#483 of 976)
No single metric tells the full story. See the NSE:IOLCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IOL Chemicals And Pharmaceuticals Business Description
IOL Chemicals And Pharmaceuticals Ltd is an India-based pharmaceutical company. The primary activity of the group is the manufacturing and sale of drugs and organic chemicals. The business activity is functioned through the Chemicals and Pharmaceutical segments. The Chemicals segment produces and sells chemicals such as Ethyl Acetate, Acetic Anhydride, Acetyl Chloride, Mono Chloro Acetic Acid, and Iso Butyl benzene, whereas the Pharmaceutical segment produces and sells various active pharmaceutical ingredients such as Ibuprofen, Metformin, Fenofibrate, Lamotrigine, and others. It derives prime revenue from the Pharmaceutical segment. Geographically, the group's products are sold in both the Indian and international markets.
63GF Score
Get the complete analysis for NSE:IOLCP
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:IOLCP has been successfully added to your 
